Long-term experience with pituitary tumors

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to gather and analyze clinical, biochemical, morphological, and pathological data from over 1600 patients who underwent neurosurgical removal of pituitary tumors over the past 20 years. It focuses on understanding the epidemiology and prognosis of pituitary adenomas and other related tumors, which are considered rare. The study seeks to identify prognostic factors that could help predict outcomes for patients with these conditions. By compiling extensive data, the research aims to contribute to a better understanding of the natural history of pituitary diseases.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patients underwent surgery for pituitary tumors;
* pathology diagnosis of pituitary tumors;
* patients older then 18 years at diagnosis of pituitary tumors;
* 2 years follow-up;

Exclusion Criteria:

* age lower then 18 years
* follow-up shorter than 2 years

Where it's running

• Fondazione Policlinico Gemelli IRCCS
  Rome, It, Italy Recruiting

Study contacts

• Principal investigator: Francesco Doglietto, Prof — Fondazione Policlinico Universitario Agostino Gemelli IRCCS
• Study coordinator: Francesco Doglietto, Prof
• Email: francesco.doglietto@policlinicogemelli.it
• Phone: +390630155701

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Investigating the effects of endoscopic skull base surgery on smell

  This study tests how endoscopic skull base surgery affects the sense of smell in patients to better understand any smell-related problems that might happen after the surgery.

  Recruiting Universitaire Ziekenhuizen KU Leuven · Leuven, Vlaams-Brabant and 2 other locations · NCT06874426

• Role of LH and hCG in adults being evaluated for endocrine disorders

  This study looks at whether levels of luteinizing hormone (LH) and hCG in adults undergoing endocrine evaluation relate to their disease presence and outcomes.

  Recruiting Copenhagen University Hospital at Herlev · Herlev · NCT07824102

• Panitumumab-IRDye800 for guiding brain tumor surgery

  A tiny dose of panitumumab-IRDye800 is tested to see if it helps visualize brain tumors during surgery in adults.

  Recruiting Early Phase 1 Vanderbilt-Ingram Cancer Center · Nashville, Tennessee · NCT07493447

• Fluid-based PET imaging to locate ACTH-secreting pituitary adenomas in Cushing disease

  This study tests whether FET PET/CT scanning can accurately locate ACTH-secreting pituitary adenomas in adults with Cushing disease who are planning pituitary surgery.

  Recruiting Early Phase 1 Mayo Clinic · Rochester, Minnesota · NCT07460232

• FET-PET/MRI to locate small hormone-producing pituitary adenomas

  This trial tests whether a special PET/MRI scan called FET-PET/MRI can find small hormone-producing pituitary adenomas in adults whose standard MRI is negative or unclear.

  Recruiting Phase 1 Mayo Clinic · Jacksonville, Florida · NCT07456878

• Intraoperative contrast-enhanced ultrasound to locate pituitary adenomas in Cushing's disease

  This pilot tests whether using contrast-enhanced ultrasound during transsphenoidal surgery helps surgeons find and remove pituitary adenomas in people with Cushing's disease.

  Recruiting Mayo Clinic · Rochester, Minnesota · NCT07335315

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.